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SUMMARY. Compounds 5-7 were synthesized from 4-tetralones with o-iodoanilines by a radical nucleophilic
substitution or SRN1 reaction, and were pharmacologically evaluated in order to establish their possible antago-
nistic action on the central dopaminergic receptors. Behavioural parameters, such as stereotypy in rats were mea-
sured after intracerebroventricular administration of these compounds at doses of 10 μg/5 μL. Our results
demonstrate that compounds 5-7 do not affect stereotypy behaviour. However, they inhibit the apomorphine-in-
duced stereotypy behaviour, suggesting the involvement of the central dopaminergic system. Also we observe
that there is a concordance between the behavioural profiles induced by our compounds and those reported for
clozapine 8 and ziprasidone 9. It is plausible to suggest that compounds 5-7 could be acting as potential atypical
antipsychotic agents. Quantum calculations performed on the basis of a comparative conformational study of
their structures indicate a stereoelectronic similarity between the basic nuclei of compounds 4 and 5-7. In addi-
tion Molecular Dynamics (MD) simulations performed on compounds 5-7 at the binding site of dopamine D2 re-
ceptor suggest that these compounds could interact with the human D2 dopamine receptors.
